Rutikbhai Desai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Rutikbhai Desai has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Urvish K. Patel
Department of Public Health, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
2 shared publications - Abbas Altamimi
Vancouver, British Columbia
1 shared publication - Abdur Raheem
Department of Internal Medicine, Texas Tech University Health Sciences Center at Permian Basin, Odessa, USA
1 shared publication - Appala Suman Peela
Department of Family Medicine, UNC Health Southeaster, Lumbertonn, NC 28358, USA
1 shared publication - Arpankumar Patel
Internal Medicine, GMERS Medical College, Ahmedabad, India
1 shared publication - Candida Pinto
Public Health, Icahn School of Medicine at Mount Sinai, New York, USA
1 shared publication
Latest Publications
- 9 March 2022
- Published by Springer Nature in SN Comprehensive Clinical Medicine
- Vol. 4 (1) , 1-6
Inflammatory Myofibroblastic Tumor in the Inguinal Canal: a Rare Case Report and a Literature Review
- 9 March 2022
- Published by Springer Nature in SN Comprehensive Clinical Medicine
- Vol. 4 (1) , 1-6
Inflammatory Myofibroblastic Tumor in the Inguinal Canal: a Rare Case Report and a Literature Review
- 26 February 2022
- Published by Springer Nature in SN Comprehensive Clinical Medicine
- Vol. 4 (1) , 1-12
Umbrella Meta-analysis Evaluating the Effectiveness of ViV-TAVI vs Redo SAVR
- 26 February 2022
- Published by Springer Nature in SN Comprehensive Clinical Medicine
- Vol. 4 (1) , 1-12
Umbrella Meta-analysis Evaluating the Effectiveness of ViV-TAVI vs Redo SAVR
- Open Access
- 18 October 2021
- Published by Springer Nature in Cureus
- Vol. 13 (10)
Post-Hemorrhagic Hydrocephalus and Outcomes Amongst Neonates With Intraventricular Hemorrhage: A Systematic Review and Pooled Analysis
Introduction Intraventricular hemorrhage (IVH) is a common cause of morbidity and mortality in preterm neonates. IVH leads to complications such as posthemorrhagic hydrocephalus (PHH), which commonly occurs in neonates with a more severe degree of IVH. Hence, we aimed to evaluate the characteristics and outcomes of PHH in neonates with IVH. Methods We performed a systematic review of cases reported from January 1978 to December 2020 through the PubMed database, using Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and the keywords 'intraventricular hemorrhage,' 'cerebral intraventricular hemorrhage,' and 'newborn.' A total of 79 articles were considered for analysis, and data on neonatal and maternal characteristics and outcomes were collected. The analysis was performed by using the chi(2) test, Wilcoxon rank-sum test, and multivariate logistic regression model. Results We analyzed a total of 101 IVH cases, 54.5% were male and 62.4% preterm. Thirteen point nine percent (13.9%) presented with grade I, 35.6% grade II, and grade III respectively, and 8% grade IV IVH. Among the 59 (58.4%) neonates with PHH, 33.6% had resolved PHH and 24.8% had unresolved. In adjusted regression analysis, we found that neonates with resolved PHH have lower odds of having neurodevelopmental delay (OR:0.15, 95%CI:0.03-0.74; p=0.02) and death (OR:0.9;95%CI:0.01-0.99; p=0.049) as compared to unresolved PHH. Conclusion Our study showed that neonates with resolved PHH have a statistically significant lower risk of neurodevelopmental delay (NDD) and mortality. Future studies should be planned to evaluate the role of treatment and its effect on outcomes in IVH neonates with PHH as a complication.
- 18 October 2021
- Published by Springer Nature in Cureus
- Vol. 13 (10)
Open AccessPost-Hemorrhagic Hydrocephalus and Outcomes Amongst Neonates With Intraventricular Hemorrhage: A Systematic Review and Pooled Analysis
Introduction Intraventricular hemorrhage (IVH) is a common cause of morbidity and mortality in preterm neonates. IVH leads to complications such as posthemorrhagic hydrocephalus (PHH), which commonly occurs in neonates with a more severe degree of IVH. Hence, we aimed to evaluate the characteristics and outcomes of PHH in neonates with IVH. Methods We performed a systematic review of cases reported from January 1978 to December 2020 through the PubMed database, using Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and the keywords 'intraventricular hemorrhage,' 'cerebral intraventricular hemorrhage,' and 'newborn.' A total of 79 articles were considered for analysis, and data on neonatal and maternal characteristics and outcomes were collected. The analysis was performed by using the chi(2) test, Wilcoxon rank-sum test, and multivariate logistic regression model. Results We analyzed a total of 101 IVH cases, 54.5% were male and 62.4% preterm. Thirteen point nine percent (13.9%) presented with grade I, 35.6% grade II, and grade III respectively, and 8% grade IV IVH. Among the 59 (58.4%) neonates with PHH, 33.6% had resolved PHH and 24.8% had unresolved. In adjusted regression analysis, we found that neonates with resolved PHH have lower odds of having neurodevelopmental delay (OR:0.15, 95%CI:0.03-0.74; p=0.02) and death (OR:0.9;95%CI:0.01-0.99; p=0.049) as compared to unresolved PHH. Conclusion Our study showed that neonates with resolved PHH have a statistically significant lower risk of neurodevelopmental delay (NDD) and mortality. Future studies should be planned to evaluate the role of treatment and its effect on outcomes in IVH neonates with PHH as a complication.